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Introduction
Chronic, low-grade systemic inflammation is a recognized risk factor for development of chronic diseases, including coronary heart disease (CHD) [1] . Dietary intakes have been shown to affect inflammation via both pro-inflammatory and anti-inflammatory mechanisms [2] . Healthy dietary patterns, which focus on foods rather than single nutrients, have been shown to be anti-inflammatory [3, 4] . Among these, the Mediterranean diet (MedDiet) has the strongest evidence for improvement in markers of inflammation [5, 6] .
However, the effect of the MedDiet on biomarkers of inflammation is unclear in patients with CHD [7] .
The Dietary Inflammatory Index (DII ® ) is a literature-derived dietary score which incorporates 45 nutritional factors that are known to modulate inflammatory markers, in either a pro-or anti-inflammatory manner [8] . This method of characterizing diet differs from other dietary pattern adherence scores as it was formulated based on findings evident in the literature relating diet to inflammatory cytokine signaling pathways. This is fundamentally different than patterns of food intake that are associated with a particular set of dietary recommendations (e.g., the Alternative Healthy Eating Index in relation to the American Food Pyramid) [9] or a culinary tradition (e.g., the MedDiet) [10] . Since its development, the DII has been applied to diet intake data in a variety of study cohorts to indicate associations with cardiovascular risk factors and CHD [11] . A higher (more pro-inflammatory) DII score has been associated with the inflammatory markers C-reactive protein (CRP) [12] , tumor necrosis factor-alpha (TNF-α) [13] , and interleukin (IL)-6 [14] , incidence of metabolic syndrome, blood pressure and triglycerides [15] , obesity [16] , and greater incidence of
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cardiovascular events [17] [18] [19] . The DII offers an attractive alternative assessment tool to laboratory-based measurement of inflammatory cytokines, which are obtained through invasive means, tend to be costly, and are not routinely available in existing studies.
The DII also provides a method by which established dietary patterns can be compared for their probable anti-inflammatory effect. For instance, a one-day meal plan of a traditional
MedDiet had a strong anti-inflammatory DII score [20] and greater MedDiet adherence has been negatively associated with DII scores [16, 21] . The DII also has been demonstrated to be inversely associated with healthy eating scores based on American dietary guidelines [9] .
An improvement in DII score can therefore be achieved through healthy diet intervention, which in turn could reduce inflammation and other cardiometabolic risk markers, as well as prevent CHD. To our knowledge only two studies have assessed the impact of diet intervention on the DII. One of these trials showed short (2-month), but not longer-term (6-month), improvement in DII with vegetarian compared to omnivorous diets in a small cohort (n=63) of overweight adults [22] . The other study of a large cohort (n=14, 339) of postmenopausal women reported modest improvement in DII after 6-years on a low-fat diet [23] .
Neither of these studies, however, assessed whether the reduction in DII score achieved with improved diet led to a change in inflammatory markers.
Current recommendations in Australia promote a low-fat diet for the prevention of CHD [24] , for which there is some evidence to suggest this type of diet is associated with reduced DII scores [9] . A MedDiet, by nature of its composition, is likely to lead to a more antiinflammatory DII score. The impact of adherence to a MedDiet on DII scores is of interest both because of the popularity of Mediterranean cuisine and concern about chronic, low-
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grade, systemic inflammation. Therefore, our objectives were to determine (1) how the DII score of a MedDiet compared with that of a low-fat diet, (2) the impact of randomization to an intervention with these two diets for 6-months on change in DII score and CRP and IL-6 (two inflammatory biomarkers on which the DII development was based) [8] , and (3) the association between improvement in MedDiet adherence score and DII score, in an adult population with CHD. We hypothesized that the prescribed MedDiet model would have a lower DII score (i.e., greater dietary anti-inflammatory potential) than that of the low-fat diet, and that this would translate to greater improvement in DII score and inflammation in participants randomized to the MedDiet intervention. We also hypothesized an association between improvement in MedDiet adherence and DII scores.
Methods and Materials
Study design
The AUStralian MEDiterranean Diet Heart Trial (AUSMED Heart Trial) is a multicenter, parallel design, randomized controlled trial (RCT) for the secondary prevention of CHD in a multi-ethnic Australian population (Australia and New Zealand Clinical Trials Register:
ACTRN12616000156482, http://www.anzctr.org.au/). The trial involves 6-month intervention with a MedDiet versus low-fat diet and a 12-month follow up to assess the primary outcome of aggregate cardiovascular events. The present study investigated the 6-month effect of two dietary interventions (MedDiet and low-fat diet) and the impact that MedDiet adherence had on DII scores (i.e., inflammatory potential of the diet), as well as the individual effects of the diets on CRP and IL-6 in a pilot cohort of patients with CHD.
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Participants and recruitment
Between 2014 to 2016, patients were recruited from two teaching hospitals in Melbourne, Australia. The study is being conducted in accordance with the CONSORT guidelines [25] and the guidelines laid down in the Declaration of Helsinki [26] . settings. Eligible and interested patients attended a pre-baseline appointment where the study was explained in detail, forms and equipment were provided, consent was obtained and randomization was conducted.
Randomization and interventions
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Enrolled participants were randomly assigned in a 1:1 ratio to the MedDiet group or the lowfat diet group. Randomization tables were developed by the trial statistician using a computer generated stratified approach based on sex, age (<55, 55 to 65 and >65 years) and history of AMI (yes/no). Baseline, 3-month and 6-month face-to-face appointments were conducted to obtain anthropometry, biomarkers and dietary data and for counselling with the dietitian. Five short phone reviews for follow-up dietary counselling with the dietitian also occurred across the 6-months, at weeks 3, 6, and 9 and months 4 and 5. Telephone-delivered lifestyle advice previously has been demonstrated to be effective for reducing coronary risk factors in the Australian setting and is a low-cost intervention method [29] . Different dietitians worked with the two different diet study groups to prevent contamination. Consultation frequency and data collection time points were consistent across the two intervention groups. All participants continued to receive standard medical care provided at their respective hospital or primary care settings; however, they were instructed not to engage in any nutritional interventions, including cardiac rehabilitation or other research trials for the duration of this study.
Mediterranean diet
The rationale and development of the MedDiet intervention has been explained in detail elsewhere (George, et al., 2018, manuscript under preparation). It was designed based on the principles of the traditional Cretan MedDiet [30] , including information from seminal intervention trials conducted in Mediterranean populations [31, 32] , trials conducted in Australia where MedDiet foods and meals were provided [33, 34] and the Hellenic dietary guidelines [35] . The diet was modelled via a 2-week meal plan incorporating key dietary components of a MedDiet and a mix of traditional and modified recipes considered to be realistic options for multi-ethnic Australians. In terms of contribution to total energy
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A C C E P T E D M A N U S C R I P T Poultry, eggs and feta cheese were recommended in moderation. For participants choosing to consume alcohol, red wine was suggested to be consumed in moderation (1-2 standard glasses) with meals. To facilitate dietary compliance and to encourage intake of staple Mediterranean foods less familiar to this population, a hamper was provided to participants at baseline and 3-months. Each hamper included 6L EVOO (to achieve 60-80mL/day) and 1.2kg nuts (almonds, walnuts and hazelnuts to achieve 30g/day) as well as samples of tinned tuna and salmon, canned legumes and Greek yoghurt.
Low-fat diet
Participants in the low-fat diet group were instructed to follow the standard diet recommendations provided to cardiac patients in Australia at the time this study was developed (in 2014), with a matched counselling frequency and set-up to that of the MedDiet
Recommendations from the Australian National Heart Foundation as well as the Australian Dietary Guidelines and Nutrient Reference Values were consulted for design of the low-fat diet [24, 36, 37] . In terms of contribution to total energy consumption, target macronutrient intakes were <30% total fat, <7% saturated fat, 45-65% carbohydrate, 15-25% protein and ≤5% alcohol. Food group recommendations included daily intake of grains and cereals (mostly whole grains, 5-7 serves/day), vegetables (5-6 serves/day), fruit (2 serves/day), protein foods (2-3 serves/day) and low-fat dairy foods (2 serves/day) [36] . Based on macronutrient and food group targets, a 1-week meal plan was created to model a comparative nutrient profile for this diet and to generate a resource for participants (Table S1 in Supplemental Materials provides an example of one day). Resources for label reading, low-fat cooking and recommended daily food group serves also were provided. To aid compliance and encourage their continuation in the trial, participants were provided with a supermarket voucher at their three face-to-face appointments.
In both study groups the dietary advice was tailored to each individual through clientcentered counselling and goal setting with the dietitian [38, 39] . Both diets were prescribed ad libitum to achieve weight maintenance with no specific recommendations on energy restriction. There was some cross-over in the general food group recommendations between the low-fat diet and the MedDiet, including daily intake of vegetables, fruit and wholegrain cereals and limited processed foods. However, the MedDiet specifically included promotion of EVOO, nuts, leafy greens, tomatoes, onion, garlic, legumes, oily fish and fermented dairy foods and more significantly reduced intake of red meat, which were not key components of the low-fat diet [40] .
Measurements
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This study reports only on baseline and 6-month data measurements. Medical conditions related to eligibility were collected in the screening process using hospital records and by questionnaire at the pre-baseline appointment. Sociodemographic and clinical characteristics were collected through a self-report survey completed at baseline, which included details on type, dose and frequency of medication and supplement use. Exercise was not a target of this intervention, however physical activity levels were assessed by triaxial Actigraph accelerometer (WGT3X-BT; Actigraph Corp, Florida, United States) worn by participants 7 days prior to each face-to-face appointment. Time spent in moderate-to-vigorous physical activity (MVPA) minutes per week was determined based on established criteria [41] . Weight and height were measured, after an 8-h fast, using international standards for anthropometric assessment [42] by trained research personnel. Body weight was measured to the nearest 0.1kg using calibrated digital scales, without shoes and after removal of heavy jewelry, outer layers of clothing and pocket contents. Height was measured to the nearest 0.1cm, while barefoot using a wall-mounted stadiometer. Body mass index was calculated as weight (kg) / height (m 2 ) and overweight was classified as >25 kg/m 2 [43] . A fasting blood sample was taken from the antecubital vein using standard venous puncture techniques. All blood samples were processed immediately and aliquots were stored at -80°C until assay. Serum high sensitivity (hs)-CRP levels were measured at a commercial laboratory (Dorevitch Pathology Pty Ltd, Heidelberg, Australia) by chemical analyzer (Cobas Integra 400, Roche).
Serum hs-IL-6 levels were measured by enzyme-linked immunosorbent assay (ELISA) (Abcam, #ab46042, detection sensitivity <0.81 pg/mL) in duplicate.
Dietary assessment
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Participants completed a 7-day food diary in household measures the week prior to the baseline and 6-month appointments. The diary included type, brand, quantity and cooking methods for consumed foods, with missing details clarified by the dietitian at the appointment. All food diaries were entered into FoodWorks8 ® (Xyris software Australia Pty Ltd), using the most up-to-date databases AUSNUT 2013, AusBrands 2015 and AusFoods 2015 for nutrient intake analyses. Any day recorded in the food diary that was considered to represent a highly abnormal intake for the participant was excluded from entry into FoodWorks8. This exclusion was applied to only two participants for reasons of religious fasting (three days) and nil intake due to acute illness (one day). The 2-week MedDiet and 1-week low-fat diet meal plans were designed against the desirable macronutrient profile using FoodWorks8 analysis. The 14-point Mediterranean Diet Adherence Screener (MEDAS), generated and validated for the PREDIMED study [44] , was measured at baseline and 6-months for each participant. Dietitians assisted participants to complete the MEDAS during consults for the MedDiet group and calculated the score retrospectively for the low-fat diet group using 7-day food diary data in order to avoid contamination with the MedDiet principles. A higher score is reflective of better adherence to a traditional MedDiet pattern, with a score of 9 or above out of 14 considered an acceptable adherence criterion [45] .
Dietary Inflammatory Index (DII ® )
The development [8] and validation [12] of the DII has been described elsewhere. Through evaluation of peer-reviewed literature published between 1950 and 2010, the DII score is based on 1943 articles that examined the association between inflammation and 45 individual nutrient, food or flavonoid intake parameters (listed in Table 2 ). Points were assigned to each of these parameters according to whether: 1) they increased (+1), decreased (-1) or had no (0)
ACCEPTED MANUSCRIPT
A C C E P T E D M A N U S C R I P T
effect on the four established pro-inflammatory biomarkers; IL-1, IL-6, TNF-α and CRP or 2) decreased (+1), increased (-1) or had no (0) effect on the two established antiinflammatory biomarkers; IL-4 and IL-10. The score for each of the food parameters was weighted according to the study design employed and total number of research articles.
Overall parameter-specific inflammatory effect scores were then calculated based on the ratio of the total weighted number of articles to the weighted pro-and anti-inflammatory articles for each parameter followed by subtracting the anti-from the pro-inflammatory fraction.
Parameters which had a robust pool of literature, i.e. greater than the median number of 236 weighted articles, were assigned the full value of that score. Parameters with the total article weight less than 236 were adjusted by dividing it by 236 and then multiplying this fraction by the previously defined inflammatory effect score.
In this study, the DII was computed twice in the participants, at baseline and after 6-months of intervention. Our assessment of the DII included all 45 of its parameters. Dietary intake data were adjusted against a reference global daily mean and standard deviation intake for each parameter to obtain a Z-score. The global intake data was based on consumption data from 11 countries around the world. To further reduce the effective skewness, each Z score was converted to a proportion (i.e., values ranging from 0 to 1) and this value was centered on zero by multiplying by 2 and subtracting 1. This centered proportion score for each intake parameter was multiplied by its respective parameter-specific inflammatory effect score to obtain the parameter-specific DII score. Each of these 45 scores were then summed to obtain an overall DII score for each individual and meal plan. Finally, the DII score for participant data was re-calculated with the inclusion of nutrient supplement intake (DIIdiet+supplements).
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The intake values for most of the DII parameters (energy, protein, carbohydrate, total fat, MUFA, PUFA, omega-3, omega-6, saturated fatty acids, trans fat, cholesterol, fiber, alcohol, caffeine, folate, beta carotene, vitamin A, vitamin B6, vitamin B12, vitamin C, vitamin E, iron, magnesium, niacin, riboflavin, selenium, thiamin and zinc) were obtained from FoodWorks8 nutrient analyses of the food diaries or meal plans. For the omega-6 component only intake of linoleic acid was available. Isolated food components in the DII (green/black tea, garlic, ginger, onion, pepper, rosemary, saffron, turmeric and thyme/oregano) were extracted from the food diaries and meal plans and the total daily intake in grams calculated.
Vitamin D was calculated from the 7-day food diaries and meal plans using an electronic
Australian nutrient table database [46] . Intake of eugenol was calculated based on the recognized content in cloves in Phenol Explorer [47] . 
Statistical analyses
Participants who did not complete the intervention were excluded from analyses. As this study represented an exploratory analysis of a pilot cohort, a power calculation was not performed [48] ; however, literature was consulted to determine if a significant effect on DII could be expected in the current sample. Because randomization to a vegetarian diet compared to a healthy omnivorous diet (total n=26) resulted in a significant improvement in DII (mean change of −1.4, p<0.05) after 2-months [22] , it was therefore expected that our MedDiet derived from traditional Cretan (Greek Mediterranean) principles would be
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associated with even lower DII scores [20] and an even greater reduction in DII than a low-fat diet in our participant sample (total n=56) after 6-months. A C C E P T E D M A N U S C R I P T Figure 1 demonstrates the randomization to diet study groups and completion of study appointments. Of the 35 participants randomized to the low-fat diet group, 31 started and 29 completed the intervention. Of the 37 participants randomized to the MedDiet group, 35 started and 27 completed the intervention. Participants dropped out for medical or family related issues or were lost to follow up. The drop-outs had a significantly higher proinflammatory DII score, with a mean baseline DII score of 1.76 ± 2.3 compared to -0.28 ± 2.7
Results
Participants
in the completers at baseline (p=0.047). The drop-outs also had a significantly lower median intake of fiber at baseline with 19.5 (3.4) vs. 24.9 (15.5) g/day (p=0.01). For all other measured variables the drop-outs were similar to those who completed the study.
Sociodemographic, medical and lifestyle characteristics between the diet study groups at baseline are reported in Table 1 . Overall, the participants represented a middle to older-aged adult (mean age 62 ± 9 years), mostly male (84%) group, who were from a variety of ethnic backgrounds (55% Australian, 18% Asian, 17% European, 5% British, 4% African and 3%
North American). More than 80% were overweight, 29% had diagnosed type 2 diabetes mellitus and 70% had experienced an AMI. The median time since recent cardiac event was less than 6-months. All participants were taking medications, of which the most common were anti-platelets (91%), statins (89%) and a range of anti-hypertensives. Less than half the cohort were taking nutrient supplements, of which vitamin D (20%), omega-3 (16%) and multivitamins (14%) were the most common. Few participants (13%) were current smokers, the majority had attended a cardiac rehabilitation program (80%) and more than one third had
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previously seen a dietitian. There were no significant differences between the study groups for any of these characteristics at baseline. For intake of energy, contribution to energy from macronutrients, and micronutrients there also were no significant differences between the study groups. The low-fat diet participants did, however, have a significantly higher median intake of fruit compared to the MedDiet group, with 1.9 (1.2) versus 0.9 (1.2) serves per day (p=0.006), with no other differences in food group intake at baseline observed.
DII of model meal plans
Supplementary Table S1 provides an example of one day from each of the intervention diet meal plans and Table 2 reports on the mean daily intake for each of the 45 DII parameters and DII score for each meal plan. Both meal plans had anti-inflammatory (-) DII scores, but the meal plan for the MedDiet was markedly more anti-inflammatory than that of the low-fat diet (-4.55 vs. -0.33, respectively). The meal plans comparatively, contained some key differences for intake of DII parameters. The MedDiet was higher in the pro-inflammatory nutrient parameter of total fat content, but also higher in numerous anti-inflammatory parameters of the index (MUFA, PUFA, omega-3 and -6, fiber, alcohol, vitamin A, D and E, flavonoids, garlic, onion, rosemary and thyme/oregano).
Adherence to MedDiet
MEDAS score significantly increased in the MedDiet group from 5.52 ± 2.2 at baseline to 10.89 ± 1.6 at 6-months (5.37, p<0.001, 95%CI 4.56, 6.18). The low-fat diet group also significantly improved their score from 4.76 ± 1.9 at baseline to 6.00 ± 2.0 at 6-months (1.24, p=0.002, 95%CI 0.46, 2.02). The change in the MedDiet group was significantly greater than 
Impact of diet interventions on DII and inflammatory markers
Baseline and 6-month DII scores for the MedDiet and low-fat diet groups are presented in Figure 2 . Within the MedDiet group there was a significant decrease from -0.40 ± 3.14 to - 
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For mean daily intake of nutrient and food parameters of the index at 6-months (Table 2) there was a significantly higher intake of total fat, MUFA, omega-6, alcohol, vitamin E, flavones, flavonols and garlic and lower intake of trans fat in the MedDiet group compared to low-fat diet group.
From baseline to 6-months there was a non-significant decrease in hs-CRP within the 
DII and MedDiet adherence
In all participants, MEDAS score had a moderate, negative correlation with DII at baseline (r= -0.44, p=0.001) and a strong, negative correlation with DII at 6-months (r= -0.54, p<0.001), which was strengthened when we adjusted for diet study group (r= -0.70, p=0.001). The 6-month change variable for MEDAS score had a weak negative correlation with change in DII score (r= -0.29, p=0.03), however this correlation did not remain when study group was controlled for (r= -0.18, p=0.34). At 6-months, half (n=28) of the pooled cohort of participants had high adherence to a traditional MedDiet (MEDAS ≥9) [45] and they Table 3 presents the corresponding adjusted differences in mean values of change in DII score across tertiles of change in MEDAS, with T3 as the referent tertile. There were no significant differences across tertiles.
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Mean change in DII score (without supplements) between adherers and non-adherers to each of the MEDAS score components at 6-months are presented in Table 4 . Participants who adhered to the recommendations for intake of olive oil as the main culinary fat and quantity, vegetables, legumes, nuts, white meat preferred to red/processed meat and sofrito sauce at 6-months had a significantly greater reduction in DII score from baseline to 6-months than those who did not adhere to those components at 6-months when adjusted for baseline DII scores.
Discussion
This study assessed both the theoretical and intervention effect on DII scores of a MedDiet versus low-fat diet in an Australian setting. Through analysis of our model meal plans, we demonstrated that the MedDiet had high anti-inflammatory potential whereas a low-fat diet
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had modest anti-inflammatory potential. In our pilot cohort of adult patients with CHD the MedDiet group adhered to the prescribed diet pattern and significantly reduced mean DII score after 6-months. By contrast, the low-fat diet did not influence DII score. After adjusting for baseline values, the MedDiet group significantly decreased mean DII score in comparison to the low-fat diet group. These results support our hypothesis that a MedDiet would improve DII score more significantly than a low-fat diet. Furthermore, when data for both intervention groups were pooled, greater MedDiet adherence scores significantly correlated with lower DII scores at baseline and 6-months. However, our results demonstrated that the MedDiet did not significantly reduce levels of inflammatory biomarkers hs-CRP and hs-IL-6, which was unexpected given the magnitude of improvement in DII score achieved with that diet.
The high anti-inflammatory potential of a MedDiet model was previously demonstrated in a one-day meal plan based on traditional Cretan MedDiet principles [20] . The analysis in that study also included the full 45 parameters of the index and produced a highly antiinflammatory DII score of -3.96, which is comparable to the total score of -4.55 for our 2-week MedDiet meal plan. The slightly lower DII score of our MedDiet could be explained by the incorporation of additional herbs and spices, its higher isoflavone content due to inclusion of soy and linseed bread, which also has a high content of omega-3 PUFA, and a 2-week period with increased capacity to capture greater food and nutrient variety.
Despite both interventions representing healthy dietary patterns, the meal plan for the MedDiet had much greater anti-inflammatory potential than that of the low-fat diet. For the MedDiet model there were higher concentrations of nutrient components which are antiinflammatory in the index, including MUFA, PUFA, fiber, alcohol, vitamins and flavonoids. This is reflective of the higher content of EVOO, nuts, vegetables, fruits, herbs, oily fish and
wine in the MedDiet. The low-fat meal plan had a higher content of carbohydrates, protein and cholesterol, which are each pro-inflammatory parameters of the index. Previously, higher participant adherence to healthy low-fat diet patterns has been demonstrated to be associated with lower DII scores [9] . However, our results are the first to show the theoretical DII score for a low-fat diet model.
Adherence to the MedDiet in our multi-ethnic cohort was inversely related to DII at baseline and 6-months. Our experimental data also demonstrated increasing MedDiet adherence score correlated with a lowering of DII; however, this was not significant when diet study group was accounted for. The association between higher adherence to a traditional MedDiet pattern and a lower DII score has previously been demonstrated in cross-sectional analyses.
In over 7,000 Spanish participants enrolled in the PREDIMED trial, adherence to the MedDiet was higher in the lowest quintile of DII scores [16] . In a cohort of over 40,000
Australian, Italian or Greek-born Australians, there was an inverse correlation between the DII and MedDiet score [21] .
Despite clear evidence to support the anti-inflammatory DII of the traditional MedDiet pattern, it had not previously been shown how a MedDiet intervention can change dietary intake and subsequently DII scores. This was important to consider in our non-Mediterranean cohort, where adherence to a MedDiet was low at baseline and a low-fat diet is still considered the standard recommendation. Our results demonstrated that a MedDiet intervention can be adhered to and leads to a significant reduction in DII score in a multiethnic cohort with chronic cardiovascular disease. Comparatively, prescription of the low-fat diet did not significantly change DII. We must recognize that in this cohort of patients with diagnosed CHD, the majority had received some type of low-fat dietary advice prior to
entering this study. Nonetheless, the theoretical and actual scope for improvement in DII with a low-fat diet was much lower than the MedDiet. At the end of the interventions, significant dietary intake differences between the groups mirrored many of the differences in the two model meal plans (such as dietary fats, alcohol, vitamin E and flavonoids).
Our findings add to the limited available literature testing the effect of healthy diet interventions on the DII. Randomization to plant-based diets (total n=63) demonstrated a vegan, vegetarian and pesco-vegetarian diet each reduced mean DII significantly (by -1.5, -
1.4 and -1.6, respectively) after 2 months in a predominately female cohort [22] . However, these improvements in DII scores were not maintained at 6-months. Furthermore, there was limited improvement in that trial's control groups prescribed healthy semi-vegetarian and omnivorous [22] diets, which had similar dietary prescription to our low-fat diet group. In a large cohort of postmenopausal women low-fat diet intervention achieved a modest reduction in DII score (by -0.16) between 1-year and 6-years follow-up [23] . Both of these previous trials assessed only a subset of the 45 DII parameters, 27 and 32 respectively, therefore their findings may not truly reflect the diets' inflammatory potential.
We hypothesized that improvement in DII with our MedDiet intervention would affect inflammatory markers. However, our results showed that in this pilot cohort of patients with CHD the MedDiet did not significantly improve hs-CRP or hs-IL-6. When adjusting for baseline DII score, a promising trend was observed regarding a greater reduction in hs-IL-6 in the MedDiet, compared to low-fat diet participants. A significant effect of the MedDiet compared to control diets in intervention trials on both CRP (14 studies) and IL-6 (6 studies)
has previously been confirmed [6] . However, a recent systematic review [7] which explored the effect of the MedDiet on inflammation in studies only recruiting patients with CHD,
found that there was no significant effect of Mediterranean-type diets compared to low-fat diets on CRP (4 studies) [51] [52] [53] [54] , and three of those studies also had small sample sizes (n<100). Current treatment regimens for patients with diagnosed CHD include intensive pharmacotherapy [55] . In particular, both aspirin and statin medication have pleiotropic antiinflammatory effects, which have been proposed to provide additional explanation for the impact which these medications have on reducing secondary CHD events [56, 57] . For hs-CRP, mean baseline levels in this AUSMED cohort were well within the normal range (<3mg/L) [49] ; hence, they may have had limited scope for improvement in this marker.
Observational studies have demonstrated that a more pro-inflammatory DII is associated with higher circulating levels of inflammatory markers CRP [12] and IL-6 [14] .However, the effect of prospective changes in DII scores on these markers has not previously been tested and the existing studies were not conducted in populations on intensive medications, such as our Assessment of all 45 intake parameters of the DII strengthens our results. The MedDiet differs from other healthy dietary patterns through culinary aspects such as use of herbs and spices and other plant-foods high in flavonoids. When these parameters are not included in the DII calculation, the anti-inflammatory potential of the MedDiet, particularly in comparison to the low-fat diet which does not necessarily include these components, could be underestimated. Our participants' nutrient and food intake data were collected via 7-day food diaries and data was verified with the participant by a dietitian. This method would likely
result in more accurate DII scores than with use of food frequency questionnaires or 24-h dietary records, which are the most common methods used in other published analyses [11] .
Our DII calculation also adjusted for supplement use.
Alongside our study's strengths and its novel findings, we must acknowledge some limitations. We had a small sample size, nine drop-outs were not included in our analysis and these participants had higher (more pro-inflammatory) DII scores at baseline. The majority of included participants were male, mean DII for both study groups was anti-inflammatory at baseline and mean hs-CRP levels were within the normal range. Our cohort is representative of patients with CHD on intensive pharmacotherapy, and who are potentially motivated and health conscious. Therefore, our results were affected by inadequate statistical power and are not necessarily applicable to healthy subjects, other disease populations or women.
Participants in the MedDiet group in this study were given food hampers to facilitate compliance, which is not reflective of a real-world setting. Our assessment for flavonoid intake was estimated using databases from the United States which may not accurately reflect Australian food composition. Our assessment of omega-6 was limited to linoleic acid.
Finally, our analyses were not based on intention-to-treat as the study was designed to test A C C E P T E D M A N U S C R I P T Participants were randomized to the Low-fat diet, n=29 or MedDiet, n=27. A C C E P T E D M A N U S C R I P T 
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The 45 intake parameters listed represent all which are included in the DII. The meal plans modeled the diet interventions for the low-fat diet (1-week) and the MedDiet (2-weeks). Dietary intake of the parameters by the low-fat diet (n=29) and MedDiet (n=27) participants at 6-months represents intake from foods only with supplement intake excluded. Abbreviations: DII, dietary inflammatory index; MedDiet, Mediterranean diet; MUFA, mono-unsaturated fatty acids; PUFA, polyunsaturated fatty acids; RE, retinol equivalents. a Values are daily intake for the meal plans and means ± SD for intake at 6-months. b Differences between intake of the study groups at 6-months, Independent Student's T-test or Mann-Whitney U test. c Negative number reflects an anti-inflammatory score, while positive number reflects a proinflammatory score. *Significant difference in intake of that parameter between the MedDiet and low-fat diet group participants at 6-months, p<0.05. Participants were distributed into tertiles of 6-month change in MEDAS score based on having an equal number of participants across three groups using SPSS statistical software. Abbreviations: MEDAS, Mediterranean Diet Adherence Screener; DII, dietary inflammatory index; T, tertile. a Values are adjusted differences in mean 6-month change in DII score to T3 with 95%CIs. b P-trend between tertiles, ANCOVA adjusted for baseline DII scores. 0.02* The MEDAS scoring tool was used to assess Mediterranean diet adherence in all study participants. Each of its 14 components represent a food group based intake recommendation. The data represents changes in DII score according to whether participants adhered to each of those recommendations or not at 6-months. Abbreviations: DII; dietary inflammatory index; MEDAS, Mediterranean diet adherence screener; marg, margarine. a Values are participants (n) and means ± SD. b Adjusted mean differences (95%CIs, p-values) between adherers and non-adherers, ANCOVA adjusted for baseline DII scores. *Significant difference for mean 6-month change in DII score between adherers and nonadherers to that MEDAS component at 6-months, p<0.05. 
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